Table 4 Gaps of control capacity and diagnostic/drug development presented in total 4 consultation meetings

Malaria

1

Need new diagnosis method for asymptomatic patients

2

Need innovative and safer drugs

3

Lack of techniques to distinguish abroad-imported cases from indigenous cases

4

Difficulty in finding asymptomatic patients

5

Need new surveillance system for pre-elimination period

6

More focus on the continuously increasing imported cases

Schistosomiasis japonica

1

Need higher sensitive antigen testing

2

Need new drug which can prevent reinfection

3

Need new molluscicide with less negative impact on the environment and biodiversity

4

Difficulty in testing for a moving population

5

Need innovative surveillance-response approaches system

6

Difficulty in controlling for more than 40 hosts

Echinococcosis

1

Need effective drug for short-term treatment

2

Need financial support for hygiene and sanitation in epidemic areas

3

Need long-acting antihelmintic implants or drugs to control dog infection

4

Need effective vaccine for people in epidemic areas

5

Need more sensitive serological test for field survey

6

Control of the wildlife transmission cycles of E multilocularis is difficult